Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 5122 - NIH Advisory Board for Clinical Research - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNIH Advisory Board for Clinical ResearchAgency NameDepartment of Health and Human Services
Fiscal Year2016Committee Number5122
Original Establishment Date4/1/1996Committee StatusTerminated
Actual Termination Date7/1/2016Committee URL 
New Committee This FYNoPresidential Appointments*No
Terminated This FYYesMax Number of Members*21
Current Charter Date4/26/2016Designated Fed Officer Position Title*CHIEF OPERATING OFFICER
Date Of Renewal Charter4/26/2018Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*MAUREEN
Exempt From Renewal*NoDesignated Federal Officer Middle NameE
Specific Termination AuthorityDesignated Federal Officer Last Name*GORMLEY
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPHD, MPH, RN
Specific Establishment Authority*42 USC 282(b)(16)Designated Federal Officer Phone*(301) 496-2897
Effective Date Of Authority*11/4/1988Designated Federal Officer Fax*(301) 402-0244
Exempt From EO 13875 Discretionary Cmte Designated Federal Officer Email*mgormley@mail.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Terminate
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The full NIH Advisory Board for Clinical Research (previously the Board of Governors of the Warren Grant Magnuson Clinical Center) met once this year at the NIH Bethesda campus. The ABCR Charter stipulated that the Board advised, consulted with, and make recommendations to the NIH Director, the NIH Deputy Director for Clinical Research, and the Clinical Center Director. In addition, the Board provided guidance for the incorporation of clinical research initiatives in the intramural clinical research programs by developing an integrated strategic operating plan for clinical research. This plan included: development of a shared vision for the intramural clinical research program, taking into account the clinical research visions of all ICs; made recommendations on strategies for integrating proposed research initiatives considering their possible effects on future intramural clinical research program; reviewed and recommended a strategic operating plan for the Clinical Center; and conducted an annual review of each NIH Institute’s or Center’s performance with respect to annual plans for the use of the Clinical Center’s resources. Although the scope of the Board’s responsibilities related only to the intramural clinical research program, the Board was also open to new opportunities for clinical research, including high-risk, high-impact research, research on rare diseases, and interactions between intramural and extramural clinical research programs. The Board reviewed the Clinical Center’s annual budget and provided recommendations to the Director, NIH. The Board’s recommendation was also shared with the Clinical Center Governing Board to inform their budget recommendation to the Director, NIH. The Board reviewed the process by which the Medical Executive Committee approves credential and privileging actions and continuous improvement of the quality of clinical activities in the Clinical Center. The Board also evaluated the Clinical Center’s Board of Scientific Counselors’ process for review of independent research conducted by the Clinical Center’s investigators. Additionally, the ABCR oversaw the Clinical Center's Operational Review process used to review the efficiency and quality of the operations of Clinical Center departments with the goal of containing expenditures while maximizing productivity in support of the NIH clinical research mission. Working groups were developed to address topics between full meetings of the Board in a more in depth fashion.
How is membership balanced?*The Board consists of 18 appointed members including the Chair and Vice Chair. Of the 18 members, ten are non-NIH employees and eight are NIH employees. None of the members are Clinical Center employees or employees of the NIH Deputy Director for Intramural Research. The Deputy Director for Intramural Research, the Clinical Center Director, the chair of the Medical Executive Committee, and other senior NIH leadership as determined by the NIH Director also serve as nonvoting ex officio members of the Board. The Chair and Vice Chair must be non-NIH employees.
How frequent & relevant are cmte mtgs?*The full ABCR met once in FY16 due to government closure related to weather in January and the termination of the ABCR prior to the September meeting. Agendas were developed for each meeting to address current and relevant topics and challenges pertinent to the Clinical Center, Intramural Research Program and greater NIH. During FY16, the Board provided guidance concerning the FY16 and FY17 budgets, Clinical Center departmental operational reviews, the Clinical Center Strategic and Annual Operating Plan, long-term planning for the NIH Intramural Research Program.
Why advice can't be obtained elsewhere?*Members of the group were chosen for their knowledge of health care governance and management, operational aspects of large academic health care centers, clinical research, and other areas of importance to the future development of the Clinical Center. The individual expertise and broad perspective that both the outside representatives and the NIH staff brought to the Board's deliberations were invaluable to obtaining balanced advice.
Why close or partially close meetings?The meetings of the Board were closed to the public for the discussion of personnel qualifications and performance. Section 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussion could reveal personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksThe Designated Federal Official and Committee Decision Maker roles are both held by the same individual based on assigned duties within the Center.

Reports: The committee did not produce any reports this fiscal year.

Website: This committee does not have a public website.
Member William Dahut appointment was extended beyond the date listed on the FY-2015 ACR.
This committee was terminated 7/1/2016.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentNoAction Reallocate ResourcesYes
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentDuring FY16, the Board provided guidance concerning the FY16 and FY17 budgets, future Clinical Center departmental operational reviews, Third Party Reimbursement and opening the doors to extramural investigators.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentDuring FY16, the Board provided guidance concerning the FY16 and FY17 budgets, future Clinical Center departmental operational reviews, Third Party Reimbursement and opening the doors to extramural investigators.Grants Review CommentNA
Number Of Recommendations*81Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentTwo action items were generated from the meeting held in FY16. The NIH Intramural Research Program and the Clinical Center consider all ABCR recommendations, delegates follow-up to appropriate individuals in the organization and reports progress back to the ABCR as needed. This fiscal year issues included: monitoring the FY16 budget and developing the FY17 budget, and endorsement of the Strategic and Operating Plan.Access Agency WebsiteYes
% of Recs Fully Implemented*100.00%Access Committee WebsiteNo
% of Recs Fully Implemented CommentThe percentage of recommendations implemented stated above was developed at the time the Annual Comprehensive Review report was prepared. Additional information is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentNAAccess OtherNo
Agency Feedback*YesAccess CommentNA
Agency Feedback Comment*At the beginning of each meeting, the ABCR Chair provides a summary of the minutes prior to asking for approval. Doing so reminds Board members of the action items. The Clinical Center Director’s remarks at the beginning of the meeting also include an update on the progress of the action items.Narrative Description*At the NIH Clinical Center, clinical research participants, more than 400,000 since the hospital opened in 1953, are active partners in medical discovery, a partnership that has resulted in a long list of medical milestones including development of chemotherapy for cancer; the first use of an immunotoxin to treat a malignancy (hairy cell leukemia); identification of the genes that cause kidney cancer, leading to the development of six new, targeted treatments for advanced kidney cancer; the demonstration that lithium helps depression; the first gene therapy; the first treatment of AIDS (with AZT); and the development of tests to detect AIDS/HIV and hepatitis viruses in blood, which led to a safer blood supply. Patients come from all 50 states and from around the world. Some 1,200 credentialed physicians, dentists, and PhD researchers; 620 nurses; and 450 allied health-care personnel work in patient care units and laboratories in numerous areas of clinical study. Research conducted at the NIH Clinical Center include: musculoskeletal and skin diseases; cancer; dental and craniofacial disorders; eye disorders; heart, lung, and blood diseases; infectious diseases; medical genetics; mental health; and neurological disorders. The NIH Advisory Board for Clinical Research advises, consults with, and makes recommendations to the Director, NIH, the NIH Deputy Director for Intramural Research, and the Director, Clinical Center on the integration of clinical research initiatives in the intramural clinical research programs by developing an integrated operating strategic plan for clinical research. This plan includes: development of a shared vision for the intramural clinical research program taking into account the clinical research visions of all institutes and centers; making recommendations on strategies for integrating proposed research initiatives considering their possible effects on the current and future intramural clinical research program; reviewing and recommending an annual strategic operating plan for the Clinical Center; and, conducting annual review of each NIH institute's or center's performance with respect to its annual operations plan for using Clinical Center resources.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$1,400.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$59,855.00Estimated Payments to Federal Staff*$0.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$3,409.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$3,837.00Est. Other Costs Next FY*$0.00
Total Costs$68,501.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)*0.40Est. Fed Staff Support Next FY*0.00
Cost RemarksEst Cost Remarks
Hide Section - Interest Areas

Interest Areas

No interest areas selected for this committee.
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-003788NIH Advisory Board for Clinical Research2015
 COM-004555NIH Advisory Board for Clinical Research2014
 COM-006139NIH Advisory Board for Clinical Research2013
 COM-006531NIH Advisory Board for Clinical Research2012
 COM-007965NIH Advisory Board for Clinical Research2011
 COM-008783NIH Advisory Board for Clinical Research2010
 COM-010328NIH Advisory Board for Clinical Research2009
 COM-010791NIH Advisory Board for Clinical Research2008
 COM-012092NIH Advisory Board for Clinical Research2007
 COM-012844NIH Advisory Board for Clinical Research2006
 COM-014004NIH Advisory Board for Clinical Research2005
 COM-014804NIH Advisory Board for Clinical Research2004
 COM-016032Board of Governors of the Warren Grant Magnuson Clinical Center2003
 COM-016539Board of Governors of the Warren Grant Magnuson Clinical Center2002
 COM-018014Board of Governors of the Warren Grant Magnuson Clinical Center2001
 COM-018698Board of Governors of the Warren Grant Magnuson Clinical Center2000
 COM-019811Board of Governors of the Warren Grant Magnuson Clinical Center1999
 COM-020328Board of Governors of the Warren Grant Magnuson Clinical Center1998
 COM-021400Board of Governors of the Warren Grant Magnuson Clinical Center1997